Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

343

Full text

260

Free full text

119

Publication Types

Journal Article

346

Research Support, Non-U.S. Gov't

206

Review

Research Support, N.I.H., Extramural

Clinical Trial

Research Support, U.S. Gov't, P.H.S.

Randomized Controlled Trial

Comparative Study

Research Support, U.S. Gov't, Non-P.H.S.

Clinical Trial, Phase II

Clinical Trial, Phase I

Retracted Publication

Controlled Clinical Trial

Multicenter Study

Clinical Trial, Phase III

Case Reports

Meta-Analysis

Research Support, N.I.H., Intramural

Comment

Clinical Trial, Phase IV

Publication Year

From

Quick links

Individual year

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Proto-Oncogene Proteins c-bcl-2""[mesh_terms]

348 Results

Searching titles within these results

Modulation of Radiation Biomarkers in a Randomized Phase II Study of I-MIBG With or Without Radiation Sensitizers for Relapsed or Refractory Neuroblastoma.

Julie R Park, Susan Groshen, Kevin Campbell, Angela C Evans, Stephen Wilson, Aimy Sebastian, Gabriela G Loots, Araz Marachelian, Myriam Armant, Sharmistha Pal, Daphne A Haas-Kogan, Meaghan Granger, Katherine K Matthay, Matthew A Coleman, Steven G DuBois

International journal of radiation oncology, biology, physics 2023;115(5):1115-1128

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Proto-Oncogene Proteins c-bcl-2""[mesh_terms]

Modulation of Radiation Biomarkers in a Randomized Phase II Study of I-MIBG With or Without Radiation Sensitizers for Relapsed or Refractory Neuroblastoma.

Repurposing of FDA-approved drugs as autophagy inhibitors in tumor cells.

Antisense and nonantisense effects of antisense Bcl-2 on multiple roles of Bcl-2 as a chemosensitizer in cancer therapy.

Targeting programmed cell death pathways with experimental therapeutics: opportunities in high-risk neuroblastoma.

Implication of calpain in neuronal apoptosis. A possible regulation of Alzheimer's disease.

Oblimersen Bcl-2 antisense: facilitating apoptosis in anticancer treatment.

Therapeutic potential of dietary bioactive compounds against anti-apoptotic Bcl-2 proteins in breast cancer.

Withania somnifera-derived phytochemicals as Bcl-B inhibitors in cancer therapy: A computational approach from byte to bench to bedside.

Single-Cell Visualization of Monogenic RNA G-quadruplex and Occupied G-quadruplex Ratio through a Module-Assembled Multifunctional Probes Assay (MAMPA).

Study of the functional role of Bcl-2 family proteins in regulating Ca(2+) signals in apoptotic cells.

In search of nutritional anti-aging targets: TOR inhibitors, SASP modulators, and BCL-2 family suppressors.

To be, or not to be, that is the question. Apoptosis in human trophoblast.

The role of Bcl-2 proteins in modulating neuronal Ca signaling in health and in Alzheimer's disease.

Apoptosis and cell death channels in prostate cancer.

Intracellular death platform steps-in: targeting prostate tumors via endoplasmic reticulum (ER) apoptosis.

Results for
""Proto-Oncogene Proteins c-bcl-2""[mesh_terms]